Yesilkaya C, Arıcı M, Yıldırım Y, Agca A, Demircan A, Taskapılı M
Department of Ophthalmology, Health Sciences University, Beyoğlu Eye Research and Training Hospital, Istanbul, Turkey.
Department of Ophthalmology, Health Sciences University, Beyoğlu Eye Research and Training Hospital, Istanbul, Turkey.
J Fr Ophtalmol. 2020 Oct;43(8):753-760. doi: 10.1016/j.jfo.2019.11.020. Epub 2020 Jun 30.
The objective of this study is to evaluate the preoperative and short- and long-term postoperative results in terms of visual acuity, refractive error, and corneal wavefront aberrations in patients with myopia and myopic astigmatism undergoing small incision lenticule extraction (SMILE).
Seventy-nine eyes of 52 myopes with or without astigmatism (41 right and 38 left) were enrolled in this retrospective study. The measurements included uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), spherical equivalent (SE) and wavefront aberrations. All the measurements before and after SMILE surgery were systematically recorded.
Mean preoperative UDVA was 1.19±0.24 logMAR and improved to 0.06±0.17 logMAR at the 3-year postoperative follow-up. At the conclusion of the 3-year follow-up, UDVA was better than or equal to 20/20 and 20/25 in 73% and 84% of eyes, respectively. At 1 month postoperatively, CDVA was 0.05±0.23 logMAR and significantly lower than the preoperative CDVA, 0.02±0.04 log MAR (P>0.05). However, at 1 year and 3 years after surgery, CDVA showed a significant increase compared to preoperative CDVA. At the conclusion of the 3-year follow-up, SE was -0.47 D, and 69.6% and 83.5% of the eyes were within±0.50 D and±1.00 D, respectively, of the intended correction. HOA's, coma, and spherical aberration increased significantly. No significant change in trefoil was detected.
This study showed that SMILE produces a stable, safe outcome for surgical treatment of myopia and myopic astigmatism.
本研究的目的是评估接受小切口透镜切除术(SMILE)的近视和近视散光患者在视力、屈光不正和角膜波前像差方面的术前及术后短期和长期结果。
本回顾性研究纳入了52例有或无散光的近视患者的79只眼(41只右眼和38只左眼)。测量指标包括未矫正远视力(UDVA)、矫正远视力(CDVA)、等效球镜度(SE)和波前像差。系统记录了SMILE手术前后的所有测量数据。
术前平均UDVA为1.19±0.24 logMAR,术后3年随访时提高到0.06±0.17 logMAR。在3年随访结束时,分别有73%和84%的眼睛UDVA优于或等于20/20和20/25。术后1个月,CDVA为0.05±0.23 logMAR,显著低于术前CDVA的0.02±0.04 logMAR(P>0.05)。然而,在术后1年和3年,CDVA与术前相比有显著提高。在3年随访结束时,SE为-0.47 D,分别有69.6%和83.5%的眼睛在预期矫正值的±0.50 D和±1.00 D范围内。高阶像差、彗差和球差显著增加。未检测到三叶草像差有显著变化。
本研究表明,SMILE为近视和近视散光的手术治疗带来了稳定、安全的结果。